Interventional outcomes for patients eligible for entry into the ARUBA clinical trial: a systematic review and meta-analysis

View More View Less
  • 1 Departments of Neurological Surgery,
  • | 2 Neurology, and
  • | 3 Public Health Sciences, University of Virginia Health System, Charlottesville, Virginia; and
  • | 4 Department of Neurological Surgery, University of Louisville School of Medicine, Louisville, Kentucky
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
Print or Print + Online

OBJECTIVE

A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) suggested that medical management afforded outcomes superior to those following intervention for unruptured arteriovenous malformations (AVMs), but its findings have been controversial. Subsequent studies of AVMs that would have met the eligibility requirements of ARUBA have supported intervention for the management of some cases. The present meta-analysis was conducted with the object of summarizing interventional outcomes for ARUBA-eligible patients reported in the literature.

METHODS

A systematic literature search (PubMed, Web of Science, Google Scholar) for AVM intervention studies that used inclusion criteria identical to those of ARUBA (age ≥ 18 years, no history of AVM hemorrhage, no prior intervention) was performed. The primary outcome was death or symptomatic stroke. Secondary outcomes included AVM obliteration, hemorrhage, death, and poor outcome (modified Rankin Scale score ≥ 2 at final follow-up). Bias assessment was performed with the Newcastle-Ottawa Scale, and the results were synthesized as pooled proportions.

RESULTS

Of the 343 articles identified through database searches, 13 studies met the inclusion criteria, yielding an overall study cohort of 1909 patients. The primary outcome occurred in 11.2% of patients (pooled = 11%, 95% CI 8%–13%). The rates of AVM obliteration, hemorrhage, poor outcome, and death were 72.7% (pooled = 78%, 95% CI 70%–85%), 8.4% (pooled = 8%, 95% CI 6%–11%), 9.9% (pooled = 10%, 95% CI 7%–13%), and 3.5% (pooled = 2%, 95% CI 1%–4%), respectively. Annualized primary outcome and hemorrhage risks were 1.85 (pooled = 2.05, 95% CI 1.31–2.94) and 1.34 (pooled = 1.41, 95% CI 0.83–2.13) per 100 patient-years, respectively.

CONCLUSIONS

Intervention for unruptured AVMs affords acceptable outcomes for appropriately selected patients. The risk of hemorrhage following intervention compared favorably to the natural history of unruptured AVMs. The included studies were retrospective and varied in treatment and AVM characteristics, thereby limiting the generalizability of their data. Future studies from prospective registries may clarify patient, nidus, and intervention selection criteria that will refine the challenging management of patients with unruptured AVMs.

ABBREVIATIONS

AVM = arteriovenous malformation; mRS = modified Rankin Scale; SM = Spetzler-Martin; SRS = stereotactic radiosurgery.

Supplementary Materials

    • Supplemental Tables and Fig. (PDF 645 KB)

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
  • 1

    Can A, Gross BA, Du R. The natural history of cerebral arteriovenous malformations. Handb Clin Neurol. 2017;143:1524.

  • 2

    Hanakita S, Shin M, Koga T, Igaki H, Saito N. Risk reduction of cerebral stroke after stereotactic radiosurgery for small unruptured brain arteriovenous malformations. Stroke. 2016;47(5):12471252.

    • Search Google Scholar
    • Export Citation
  • 3

    Pabaney AH, Reinard KA, Massie LW, Naidu PK, Mohan YS, Marin H, Malik GM. Management of perisylvian arteriovenous malformations: a retrospective institutional case series and review of the literature. Neurosurg Focus. 2014;37(3):E13.

    • Search Google Scholar
    • Export Citation
  • 4

    Corniola MV, Meling TR, Bijlenga P, Bernava G, Machi P, Schaller K. Posterior fossa arteriovenous malformations: experience with 14 patients and a systematic review of the literature. J Neurol Surg A Cent Eur Neurosurg. 2020;81(2):170176.

    • Search Google Scholar
    • Export Citation
  • 5

    Chen CJ, Ding D, Wang TR, Buell TJ, Ilyas A, Ironside N, et al. Microsurgery versus stereotactic radiosurgery for brain arteriovenous malformations: a matched cohort study. Neurosurgery. 2019;84(3):696708.

    • Search Google Scholar
    • Export Citation
  • 6

    Cenzato M, Tartara F, D’Aliberti G, Bortolotti C, Cardinale F, Ligarotti G, et al. Unruptured versus ruptured AVMs: outcome analysis from a multicentric consecutive series of 545 surgically treated cases. World Neurosurg. 2018;110:e374e382.

    • Search Google Scholar
    • Export Citation
  • 7

    Link TW, Winston G, Schwarz JT, Lin N, Patsalides A, Gobin P, et al. Treatment of unruptured brain arteriovenous malformations: a single-center experience of 86 patients and a critique of the A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) trial. World Neurosurg. 2018;120:e1156e1162.

    • Search Google Scholar
    • Export Citation
  • 8

    Chen CJ, Ding D, Derdeyn CP, Lanzino G, Friedlander RM, Southerland AM, et al. Brain arteriovenous malformations: a review of natural history, pathobiology, and interventions. Neurology. 2020;95(20):917927.

    • Search Google Scholar
    • Export Citation
  • 9

    Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014;383(9917):614621.

    • Search Google Scholar
    • Export Citation
  • 10

    Mohr JP, Overbey JR, Hartmann A, Kummer RV, Al-Shahi Salman R, Kim H, et al. Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial. Lancet Neurol. 2020;19(7):573581.

    • Search Google Scholar
    • Export Citation
  • 11

    Feghali J, Huang J. Updates in arteriovenous malformation management: the post-ARUBA era. Stroke Vasc Neurol. 2019;5(1):3439.

  • 12

    Magro E, Gentric JC, Darsaut TE, Ziegler D, Bojanowski MW, Raymond J. Responses to ARUBA: a systematic review and critical analysis for the design of future arteriovenous malformation trials. J Neurosurg. 2017;126(2):486494.

    • Search Google Scholar
    • Export Citation
  • 13

    Pulli B, Chapman PH, Ogilvy CS, Patel AB, Stapleton CJ, Leslie-Maszwi TM, et al. Multimodal cerebral arteriovenous malformation treatment: a 12-year experience and comparison of key outcomes to ARUBA. J Neurosurg. 2020;133(6):17921801.

    • Search Google Scholar
    • Export Citation
  • 14

    Starke RM, Sheehan JP, Ding D, Liu KC, Kondziolka D, Crowley RW, et al. Conservative management or intervention for unruptured brain arteriovenous malformations. World Neurosurg. 2014;82(5):e668e669.

    • Search Google Scholar
    • Export Citation
  • 15

    Kim BS, Yeon JY, Kim JS, Hong SC, Shin HJ, Lee JI. Gamma Knife radiosurgery for ARUBA-eligible patients with unruptured brain arteriovenous malformations. J Korean Med Sci. 2019;34(36):e232.

    • Search Google Scholar
    • Export Citation
  • 16

    Tonetti DA, Gross BA, Atcheson KM, Jankowitz BT, Kano H, Monaco EA, et al. The benefit of radiosurgery for ARUBA-eligible arteriovenous malformations: a practical analysis over an appropriate follow-up period. J Neurosurg. 2018;128(6):18501854.

    • Search Google Scholar
    • Export Citation
  • 17

    Maruyama D, Satow T, Kataoka H, Mori H, Hamano E, Orita Y, et al. Multimodal interventional treatment and outcomes for unruptured arteriovenous malformations. Acta Neurochir Suppl (Wien). 2018;129:115120.

    • Search Google Scholar
    • Export Citation
  • 18

    Lang M, Moore NZ, Rasmussen PA, Bain MD. Treatment outcomes of A Randomized Trial of Unruptured Brain Arteriovenous Malformation-eligible unruptured brain arteriovenous malformation patients. Neurosurgery. 2018;83(3):548555.

    • Search Google Scholar
    • Export Citation
  • 19

    Singfer U, Hemelsoet D, Vanlangenhove P, Martens F, Verbeke L, Van Roost D, Defreyne L. Unruptured brain arteriovenous malformations: primary ONYX embolization in ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-eligible patients. Stroke. 2017;48(12):33933396.

    • Search Google Scholar
    • Export Citation
  • 20

    Schramm J, Schaller K, Esche J, Boström A. Microsurgery for cerebral arteriovenous malformations: subgroup outcomes in a consecutive series of 288 cases. J Neurosurg. 2017;126(4):10561063.

    • Search Google Scholar
    • Export Citation
  • 21

    Javadpour M, Al-Mahfoudh R, Mitchell PS, Kirollos R. Outcome of microsurgical excision of unruptured brain arteriovenous malformations in ARUBA-eligible patients. Br J Neurosurg. 2016;30(6):619622.

    • Search Google Scholar
    • Export Citation
  • 22

    Ding D, Starke RM, Kano H, Mathieu D, Huang P, Kondziolka D, et al. Radiosurgery for cerebral arteriovenous malformations in A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA)-eligible patients: a multicenter study. Stroke. 2016;47(2):342349.

    • Search Google Scholar
    • Export Citation
  • 23

    Nerva JD, Mantovani A, Barber J, et al. Treatment outcomes of unruptured arteriovenous malformations with a subgroup analysis of ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-eligible patients. Neurosurgery. 2015;76(5):563570.

    • Search Google Scholar
    • Export Citation
  • 24

    Rutledge WC, Abla AA, Nelson J, Halbach VV, Kim H, Lawton MT. Treatment and outcomes of ARUBA-eligible patients with unruptured brain arteriovenous malformations at a single institution. Neurosurg Focus. 2014;37(3):E8.

    • Search Google Scholar
    • Export Citation
  • 25

    Pollock BE, Link MJ, Brown RD. The risk of stroke or clinical impairment after stereotactic radiosurgery for ARUBA-eligible patients. Stroke. 2013;44(2):437441.

    • Search Google Scholar
    • Export Citation
  • 26

    Hong CS, Peterson EC, Ding D, Sur S, Hasan D, Dumont AS, et al. Intervention for A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA)–eligible patients: an evidence-based review. Clin Neurol Neurosurg. 2016;150:133138.

    • Search Google Scholar
    • Export Citation
  • 27

    Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65(4):476483.

  • 28

    Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.

    • Search Google Scholar
    • Export Citation
  • 29

    Wong J, Slomovic A, Ibrahim G, Radovanovic I, Tymianski M. Microsurgery for ARUBA Trial (A Randomized Trial of Unruptured Brain Arteriovenous Malformation)-eligible unruptured brain arteriovenous malformations. Stroke. 2017;48(1):136144.

    • Search Google Scholar
    • Export Citation
  • 30

    Kim H, Al-Shahi Salman R, McCulloch CE, Stapf C, Young WL. Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors. Neurology. 2014;83(7):590597.

    • Search Google Scholar
    • Export Citation
  • 31

    Gross BA, Du R. Natural history of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg. 2013;118(2):437443.

  • 32

    Derdeyn CP, Zipfel GJ, Albuquerque FC, Cooke DL, Feldmann E, Sheehan JP, Torner JC. Management of brain arteriovenous malformations: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2017;48(8):e200e224.

    • Search Google Scholar
    • Export Citation
  • 33

    van Beijnum J, van der Worp HB, Buis DR, Al-Shahi Salman R, Kappelle LJ, Rinkel GJ, et al. Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA. 2011;306(18):20112019.

    • Search Google Scholar
    • Export Citation
  • 34

    Darsaut TE, Magro E, Gentric JC, Batista AL, Chaalala C, Roberge D, et al. Treatment of Brain AVMs (TOBAS): study protocol for a pragmatic randomized controlled trial. Trials. 2015;16:497.

    • Search Google Scholar
    • Export Citation
  • 35

    Kim H, Al-Shahi Salman Rustam, Flemming Kelly D, et al. Abstract: Long-term outcomes in unruptured brain arteriovenous malformation patients: the Multicenter Arteriovenous Malformation Research Study (MARS). Stroke. 2019;50(suppl 1):ATP585.

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 407 407 310
Full Text Views 59 59 52
PDF Downloads 73 73 65
EPUB Downloads 0 0 0